These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2667309)

  • 21. Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure.
    Wang RY; Chow JS; Chan KH; Pan HY; Wong RP
    Eur Heart J; 1984 Sep; 5(9):745-51. PubMed ID: 6499862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Natsume T; Gallo AJ; Frohlich ED
    Am J Med; 1984 Oct; 77(4A):64-73. PubMed ID: 6486158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of phentolamine and urapidil in controlling acute intra-operative hypertension in patients subjected to coronary artery bypass surgery.
    Hess W; Schulte-Sasse U; Tarnow J; Veit S
    Eur J Anaesthesiol; 1985 Mar; 2(1):21-7. PubMed ID: 3874774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of intravenous urapidil in patients with advanced left ventricular failure.
    Drobinski G; Montalescot G; Fossier JM; Grosgogeat Y
    Drugs; 1990; 40 Suppl 4():63-4. PubMed ID: 2092971
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic changes and left ventricular function in patients with hypertension during an acute trial of urapidil].
    Sirakova V; Penkov N; Penev A
    Vutr Boles; 1988; 27(5):20-3. PubMed ID: 3062899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of urapidil in patients with mild pulmonary vascular hypertension.
    Späh F; Kottmann R; Grosser KD; Schmidt U; Thieme G
    Drugs; 1990; 40 Suppl 4():69-70. PubMed ID: 2092974
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung disease.
    Späh F; Kottman R; Schmidt U
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):517-24. PubMed ID: 7515999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate hemodynamic changes produced by urapidil in normotensive and spontaneously hypertensive rats.
    Kobrin I; Gallo A; Kumar A; Pegram BL; Frohlich ED
    Clin Exp Hypertens A; 1984; 6(3):685-97. PubMed ID: 6723085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urapidil in normotensive and spontaneously hypertensive rats: the effects on systemic and regional haemodynamics and cardiac mass.
    Kobrin I; Gallo AJ; Pegram BL; Frohlich ED
    J Hypertens; 1984 Jun; 2(3):317-20. PubMed ID: 6530543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the hemodynamic effects of urapidil and flesinoxan in healthy volunteers.
    Van Zwieten PA; Bruning TA
    Blood Press Suppl; 1994; 4():19-24. PubMed ID: 7804508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Langtry HD; Mammen GJ; Sorkin EM
    Drugs; 1989 Dec; 38(6):900-40. PubMed ID: 2693046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of the multiple action antihypertensive drug urapidil.
    Mancia G
    Drugs; 1990; 40 Suppl 4():14-20; discussion 28-30. PubMed ID: 2092964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulatory changes with urapidil (Ebrantil) in general and regional anesthesia. Studies with normo- and hypertensive patients].
    Lehmann KA; Heimig T
    Anaesthesist; 1985 Sep; 34(9):435-45. PubMed ID: 4083465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental studies on the neurocardiovascular effects of urapidil.
    Gillis RA; Kellar KJ; Quest JA; Namath IJ; Martino-Barrows A; Hill K; Gatti PJ; Dretchen K
    Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sodium nitroprusside and urapidil on gas exchange and ventilation: perfusion ratios in patients with congestive heart failure.
    Adnot S; Radermacher P; Andrivet P; Dubois-Rande JL; Dupeyrat A; Lemaire F
    Drugs; 1990; 40 Suppl 4():65-6. PubMed ID: 2092972
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
    Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular effects of urapidil].
    Bousquet P; Decker N; Feldman J; Schwartz J
    J Pharmacol; 1983; 14(4):465-72. PubMed ID: 6672466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.